Rilmazafone (Rhythmy, 450191-S) is a water-soluble benzodiazepine prodrug developed in Japan. It has sedative and hypnotic effects. Rilmazafone induces impairment of motor function and has hypnotic properties. Rilmazafone has no effects on benzodiazepine receptors itself, but once inside the body is metabolised by aminopeptidase enzymes in the small intestine to form the active benzodiazepine 8-chloro-6-(2-chlorophenyl)-N,N-dimethyl-4H-1,2,4-triazolo [1,5-a] [1,4]benzodiazepine-2-carboxamide.

PropertyValue
dbpedia-owl:Drug/atcPrefix
  • none
dbpedia-owl:Drug/casNumber
  • 99593-25-6
dbpedia-owl:Drug/iupacName
  • 1-[4-chloro-2-(2-chlorobenzoyl)phenyl]-5-[(glycylamino)methyl]-N,N-dimethyl-1H-1,2,4-triazole-3-carboxamide
dbpedia-owl:Drug/pubchem
  • 5069
dbpedia-owl:atcPrefix
  • none
dbpedia-owl:casNumber
  • 99593-25-6
dbpedia-owl:iupacName
  • 1-[4-chloro-2-(2-chlorobenzoyl)phenyl]-5-[(glycylamino)methyl]-N,N-dimethyl-1H-1,2,4-triazole-3-carboxamide
dbpedia-owl:pubchem
  • 5069
dbpedia-owl:thumbnail
dbpprop:abstract
  • Rilmazafone (Rhythmy, 450191-S) is a water-soluble benzodiazepine prodrug developed in Japan. It has sedative and hypnotic effects. Rilmazafone induces impairment of motor function and has hypnotic properties. Rilmazafone has no effects on benzodiazepine receptors itself, but once inside the body is metabolised by aminopeptidase enzymes in the small intestine to form the active benzodiazepine 8-chloro-6-(2-chlorophenyl)-N,N-dimethyl-4H-1,2,4-triazolo [1,5-a] [1,4]benzodiazepine-2-carboxamide. Rilmazafone active metabolite
  • 塩酸リルマザホン (rilmazafone hydrochloride) は睡眠導入剤の一種。短-中時間作用型。日本での商品名はリスミーなど。
dbpprop:atcPrefix
  • none
dbpprop:c
  • 21 (xsd:integer)
dbpprop:casNumber
  • 99593-25-6
dbpprop:cl
  • 2 (xsd:integer)
dbpprop:eliminationHalfLife
  • 10.5 h
dbpprop:excretion
  • urine
dbpprop:h
  • 20 (xsd:integer)
dbpprop:hasPhotoCollection
dbpprop:iupacName
  • 1-[4-chloro-2-(2-chlorobenzoyl)phenyl]-5-[(glycylamino)methyl]-N,N-dimethyl-1H-1,2,4-triazole-3-carboxamide
dbpprop:molecularWeight
  • 475.328 (xsd:double)
dbpprop:n
  • 6 (xsd:integer)
dbpprop:o
  • 3 (xsd:integer)
dbpprop:pubchem
  • 5069 (xsd:integer)
dbpprop:routesOfAdministration
  • oral
dbpprop:synonyms
  • 5-([(2-aminoacetyl)amino]methyl)-1-[4-chloro-2-(2-chlorobenzoyl)phenyl]-N,N-dimethyl-1,2,4-triazole-3-carboxamide
dbpprop:width
  • 200 (xsd:integer)
dbpprop:wikiPageUsesTemplate
rdf:type
rdfs:comment
  • Rilmazafone (Rhythmy, 450191-S) is a water-soluble benzodiazepine prodrug developed in Japan. It has sedative and hypnotic effects. Rilmazafone induces impairment of motor function and has hypnotic properties. Rilmazafone has no effects on benzodiazepine receptors itself, but once inside the body is metabolised by aminopeptidase enzymes in the small intestine to form the active benzodiazepine 8-chloro-6-(2-chlorophenyl)-N,N-dimethyl-4H-1,2,4-triazolo [1,5-a] [1,4]benzodiazepine-2-carboxamide.
  • 塩酸リルマザホン (rilmazafone hydrochloride) は睡眠導入剤の一種。短-中時間作用型。日本での商品名はリスミーなど。
rdfs:label
  • Rilmazafone
  • 塩酸リルマザホン
owl:sameAs
skos:subject
foaf:depiction
foaf:page
is owl:sameAs of